Exeltis
↗Florham Park, USA (Global HQ in Madrid, Spain)
Exeltis is a global pharmaceutical organization specializing in Women's Health, Central Nervous System (CNS), Respiratory, and Dermatology. It operates as the branded division of the Spanish multinational Insud Pharma (formerly Chemo Group). The company is dedicated to providing innovative therapeutic solutions throughout every stage of a woman's life, from fertility and contraception to pregnancy and menopause.
With a presence in over 40 countries and a team of over 4,000 professionals, Exeltis leverages a global manufacturing network and R&D capabilities to bring high-quality medicinal products to market. In recent years, the company has significantly expanded its portfolio through strategic acquisitions, including the purchase of Agile Therapeutics and Viatris' women's healthcare business, solidifying its position as a leader in the reproductive health sector.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Women's Health & Reproductive Therapeutics
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:2003
Ownership:subsidiary
Status:operating
FUNDING
Stage:Late Stage (Subsidiary of Insud Pharma)
Total Raised:N/A
Investors:Insud Pharma, Bill & Melinda Gates Foundation (Grant recipient)
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved (Slynd, Twirla)
Modalities:Small molecule, Transdermal patch, Oral contraceptives, Injectables
Active Trials:10
Trial Phases:Phase 1: 2 | Phase 2: 3 | Phase 3: 4 | Phase 4: 1
FDA Approvals:12
EMA Approvals:15
CORPORATE STRUCTURE
Parent Company:Insud Pharma
Subsidiaries:Exeltis USA Dermatology, LLC, Exeltis India, León Farma (Manufacturing)
Key Partnerships:Afaxys (Public health distribution), Theranexus (Rare disease licensing), Stitch (Clinical trial patient experience)
COMPETITION
Position:Leader
Competitors:Bayer, Organon, TherapeuticsMD, AbbVie, Mayne Pharma
LEADERSHIP
Key Executives:
Lucas Sigman - CEO, Insud Pharma
Eduardo Fernandez - EVP Corporate Development, Exeltis USA
Scientific Founders:Hugo Sigman, Silvia Gold
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Exeltis. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.